Serina Therapeutics
49 hedge funds and large institutions have $5.9M invested in Serina Therapeutics in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.47% less ownership
Funds ownership: 17.33% → 16.86% (-0.47%)
4% less funds holding
Funds holding: 51 → 49 (-2)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
50% less capital invested
Capital invested by funds: $11.9M → $5.9M (-$5.97M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$51.4K |
| 2 |
State Street
Boston,
Massachusetts
|
+$41.6K |
| 3 |
Barclays
London,
United Kingdom
|
+$35.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$20.5K |
| 5 |
Goldman Sachs
New York
|
+$18.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$146K |
| 2 |
DC
Defender Capital
Charlotte,
North Carolina
|
-$117K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$44K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$41K |
| 5 |
Morgan Stanley
New York
|
-$36.3K |
SER Hedge Fund Activity: Q1 2020 in Review
49 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2020, worth a combined $5.9M — down 50% from $11.9M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SER and 6 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 10 added.
The largest buyer was Wells Fargo, adding an estimated $51.4K. The largest seller was Panagora Asset Management, exiting entirely with an estimated $146K sold.
- 49 institutional investors held Serina Therapeutics (SER) as of Q1 2020, down from 51 in Q4 2019.
- Funds reported $5.9M of Serina Therapeutics stock for Q1 2020, down 50% quarter-over-quarter.
- 6 funds opened new Serina Therapeutics positions in Q1 2020 and 7 closed out, a net change of -1 holder.
- The largest Serina Therapeutics buyer in Q1 2020 was Wells Fargo, an estimated $51.4K added.
- The largest Serina Therapeutics seller in Q1 2020 was Panagora Asset Management, an estimated $146K sold.
Based on aggregated 13F filings for Q1 2020.